KlaymanToskes files FINRA claim against LPL Financial and Principal Securities over alleged unsuitable trading

KlaymanToskes says it filed a FINRA arbitration claim seeking up to $1 million for three investors who lost money in accounts managed by former brokers Edward Munoz and Mark Ramos. The claim alleges speculative biotech and meme-stock concentration, excessive covered call trading, and supervisory failures at Principal Securities and LPL Financial.

Why it matters: - The claim alleges that retired and financially vulnerable investors were pushed into strategies that did not match their risk tolerance, objectives, or experience. - The filing raises familiar suitability and supervision issues in fee-based brokerage accounts, including concentration risk, excessive trading, and options strategies that can cap upside while leaving downside exposure. - The case seeks up to $1 million in damages, putting potential recovery and firm supervision practices in focus.

What happened: - KlaymanToskes filed a FINRA arbitration claim, Case No. 26-02246, against LPL Financial, LLC and Principal Securities, Inc. - The claim was filed on behalf of three investors who suffered substantial losses in accounts managed by former brokers Edward Munoz and Mark Ramos. - The accounts were managed first through Principal Securities and later through LPL Financial. - The firm says investors who lost money in accounts managed by Munoz or Ramos can contact attorney Lawrence L. Klayman for a free and confidential consultation at 888-997-9956 or investigations@klaymantoskes.com.

The details: - The Statement of Claim alleges Munoz and Ramos used a common strategy across the accounts. - The strategy allegedly concentrated assets in speculative biotechnology stocks and meme stocks. - The strategy also allegedly included short-dated covered call options, excessive trading, and advisory fees of up to 2%. - The investments at issue included Amarin Corporation, Inovio Pharmaceuticals, Corbus Pharmaceuticals, AMC Entertainment, Affirm Holdings, and Ebix. - The claim says nearly 80% of one investor’s savings was placed in a single biotechnology stock before the value declined sharply. - Other accounts were allegedly concentrated in volatile individual stocks instead of diversified investments. - The claim says investors were not adequately told that covered call trading could limit gains without protecting against major losses if the stocks fell. - Shares were allegedly called away and repurchased repeatedly, increasing trading activity while investors still paid advisory fees of up to 2%. - In some instances, the claim says advisory fees were charged on large cash balances that remained uninvested for extended periods. - Brokerage firms and financial professionals must assess a customer’s experience, risk tolerance, financial needs, and objectives before recommending a strategy.

Between the lines: - The allegation is not just about stock picking. It is about whether the firms had systems strong enough to flag concentration, repeat trading, and profile mismatches before losses mounted. - The complaint also suggests a potential conflict between fee generation and suitability, especially where cash sat idle and trading activity remained high. - KlaymanToskes says the case reflects a repeated pattern of exposing retirement and long-term savings to speculative stocks and an options strategy that reduced upside without buffering downside. - As of October 8, 2026, Munoz’s BrokerCheck report showed four customer disputes and one employment termination, while Ramos’s report showed one customer dispute. - Neither Munoz nor Ramos is currently registered with a FINRA member firm. - Munoz was registered with Principal Securities from 2019 through 2021 and with LPL Financial from 2021 through 2023. - Ramos was registered with Principal Securities from 2019 through 2021 and with LPL Financial from 2021 through 2024.

What's next: - The FINRA arbitration process will determine whether the investors can recover losses from LPL Financial and Principal Securities. - Investors who believe they were harmed by speculative stocks, covered call options, excessive trading, or fee-based accounts managed by Munoz or Ramos may pursue their own recovery claims through FINRA arbitration. - KlaymanToskes is directing affected investors to seek a free and confidential case review at 888-997-9956 or investigations@klaymantoskes.com.

The bottom line: - The filing argues that the losses were driven by unsuitable concentration and trading, not market luck alone, and it puts both supervision and client-profiling practices under scrutiny.